India’s pharmaceutical space has seen a flurry of deal-making activity over the last year as investors look to leverage the global supply chain diversification which has benefited the pharma and healthcare manufacturing sectors. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
